Literature DB >> 8330013

Effects of the muscarinic agonist oxotremorine on membrane fluidity in rat lymphocytes.

C Tang1, A F Castoldi, L G Costa.   

Abstract

The muscarinic agonist oxotremorine produced a concentration-dependent increase in membrane fluidity in intact viable rat splenic lymphocytes in vitro. This effect was antagonized by atropine, but only at high concentrations (1 mM), while scopolamine was ineffective. Two other muscarinic agonists, carbachol and pilocarpine, did not affect membrane fluidity in lymphocytes. The fluidizing effect of oxotremorine occurred at both 10 and 37 degrees C with a similar time-course. Oxotremorine also increased membrane fluidity in liposomes of DMPC in gel phase, although its effect was less pronounced than in lymphocytes. The data suggest that the fluidization caused by oxotremorine is primarily nonreceptor-mediated and associated with a nonspecific physicochemical effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8330013

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  4 in total

Review 1.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

2.  Ugi 4-CR Synthesis of γ- and δ-Lactams providing new access to diverse enzyme interactions, a PDB analysis.

Authors:  André Boltjes; George P Liao; Ting Zhao; Eberhardt Herdtweck; Alexander Dömling
Journal:  Medchemcomm       Date:  2014-07-01       Impact factor: 3.597

Review 3.  Membrane Interactions of Phytochemicals as Their Molecular Mechanism Applicable to the Discovery of Drug Leads from Plants.

Authors:  Hironori Tsuchiya
Journal:  Molecules       Date:  2015-10-16       Impact factor: 4.411

4.  A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans.

Authors:  Zhongshan Cheng; Chureerat Phokaew; Yi-Ling Chou; Dongbing Lai; Jacquelyn L Meyers; Arpana Agrawal; Lindsay A Farrer; Henry R Kranzler; Joel Gelernter
Journal:  Transl Psychiatry       Date:  2019-11-18       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.